Risk factors
Ani Pharmaceuticals (ANIP) risk factors
Item 1A of every Ani Pharmaceuticals Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors63 risks12 new11 dropped23 reworded
New filing emphasizes manufacturing, healthcare-law, government-pricing, reimbursement, AI, geopolitical and tariff risks, plus cash obligations on the Notes.
Filed Feb 27, 2026 - FY2024 10-K risk factors62 risks
Acquisition of Alimera introduces new ophthalmic products, international operations, and third-party manufacturing dependencies.
Filed Feb 28, 2025